Outcome of AGM
This is in continuation of our earlier letter dated September 28, 2017 informing that the detailed results of remote e-voting and the poll conducted at the Annual General Meeting ('AGM') of the Company held on September 27, 2017, as required under Regulation 44 of the SEBI Listing Regulations shall be forwarded to you on the receipt of Scrutinizer's Report.... Outcome of AGM
Proceedings of the 33rd Annual General Meeting (AGM) of the Company held on September 27, 2017, at its registered office at Ambala-Chandigarh Highway, Lalru - 140501, Punjab in pursuance to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), are enclosed herewith for your information and record please.... Outcome of AGM
Proceedings of the 33rd Annual General Meeting (AGM) of the Company held on September 27, 2017, at its registered office at Ambala-Chandigarh Highway, Lalru - 140501, Punjab in pursuance to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), are enclosed herewith for your information and record please.... Notice of Postal Ballot
We would like to inform you that the Company is conducting Postal Ballot for obtaining approval of members for passing special resolution in relation to: i. Raising of funds by way of issue of equity shares and/or other securities for an amount upto Rs.250 Crore Notice is being dispatched to the shareholders of the Company whose names appear in the Register of Members of the Company as on the cut-off date i.e. September 15, 2017... Notice of Postal Ballot
We would like to inform you that the Company is conducting Postal Ballot for obtaining approval of members for passing special resolution in relation to: i.Raising of funds by way of issue of equity shares and/or other securities for an amount upto Rs.250 Crore Notice is being dispatched to the shareholders of the Company whose names appear in the Register of Members of the Company as on the cut-off date i.e. September 15, 2017... Updates
This is with reference to the clarification sought by National Stock Exchange of India Ltd. vide e-mail dated September 14, 2017 on the announcement submitted to the Exchange dated September 13, 2017, regarding Outcome of the Board Meeting held on September 13, 2017. Relating thereto please find enclosed herewith our clarification/reply letter. Updates
In continuation to our earlier communication dated 13th September, 2017 intimating about the outcome of the Board Meeting of the Company held on 13th September, 2017, please find enclosed the details relating to demerger of real estate business of the Company through Scheme of Arrangement subject to applicable approvals, as required under Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Financial Results For The Quarter Ended 30/06/2017
We would like to inform you that the Board of the Company has, at its meeting held today, i.e 13.09.2017, inter-alia, considered and approved the following: 1.Unaudited Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended 30.06.2017 in terms of Regulation 33 of SEBI Listing Regulations.... Panacea Biotec extends pact with Apotex Inc
Panacea Biotec has expanded its existing collaboration with Canada's Apotex Inc for sales and distribution of Prasugrel tablets in the US. Panacea Biotec has expanded its existing collaboration... Press Release / Media Release
Panacea Biotec Limited has expanded its existing collaboration with Apotex Inc., the largest Canadian-owned pharmaceutical company, for sales & distribution of Prasugrel 5mg and 10mg tablets (generic version of Eli Lilly's Effient) in the USA. The Company has signed an exclusive License and Supply Agreement with Apotex for this purpose. Under the terms of the agreement, Apotex shall be responsible for sales & distribution of the product in the USA...